Baseline Characteristics of the Patient Population (n=525) Colin Berry, et al. Circulation 2007;115:1851-1857.

Slides:

Advertisements

Similar presentations

Sibbing D, et al. J Am Coll Cardiol 2009;53:

Advertisements

Reversing Atherosclerosis with Aggressive Lipid Lowering Reversing Atherosclerosis with Aggressive Lipid Lowering Presented at American Heart Association.

IVUS Use during Left Main PCI improve Immediate and Long Term Outcome Where is the Evidence? E Murat Tuzcu, MD, FACC Professor of Medicine Vice Chairman.

IVUS-VH & Vulnerable Plaque Jang-Ho Bae, MD., PhD. Heart Center Konyang University Hospital Daejeon City, S. Korea Jang-Ho Bae, MD., PhD. Heart Center.

1 CAMELOT: Study Design A Morbidity and Mortality Study Patients with documented CAD on standard-of-care therapies* (n=1997) Clinical events (morbidity.

Stents Are Not Enough: Statins Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford.

Effect of Rosuvastatin Therapy on Coronary Artery Stenosis Assessed by Quantitative Coronary Angiography in ASTEROID CM Ballantyne, 1 JS Raichlen, 2 SJ.

Slide Source: Lipids Online Slide Library Prospective Pravastatin Pooling Project: Coronary Event Rates in CARE and LIPID Patients.

ASTEROID A Study To evaluate the Effect of Rosuvastatin On Intravascular ultrasound- Derived coronary atheroma burden.

Clinical Trial Results. org The ERASE Trial: Effect of rHDL on Atherosclerosis-Safety and Efficacy Presented at American College of Cardiology Annual Scientific.

ASTEROID A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden References Nissen et al. Effect.

© 2012 EuroIntervention. All rights reserved. EuroIntervention 2011;7: Correlation between fractional flow reserve and intravascular ultrasound.

Navigating the Coronary Circulation: Angiography vs IVUS Pearls and Pitfalls Philippe L. L’Allier, MD Montreal Heart Institute Tuesday, March 27, 2007.

Comparison of the Progression of Coronary Atherosclerosis for Two High Efficacy Statin Regimens with Different HDL Effects: SATURN Study Results SJ Nicholls,

Murat Sezer, Emre Aslanger, Arif Cimen, Ebru Yormaz, Cuneyt Turkmen, Berrin Umman, Yılmaz Nisanci, Zehra Bugra and Sabahattin Umman Istanbul University,

Ho PM, et al. JAMA 2009;301: Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:

SATURN: Objective To compare the effects of rosuvastatin 40 mg versus atorvastatin 80 mg on progression of coronary atherosclerosis assessed by intravascular.

Baseline Characteristics of Cases, Controls, and Entire VA-HIT Population James D. Otvos, et al, Circulation 2006;113:

When I Use IVUS Neal Uren MD FRCP Consultant Cardiologist Royal Infirmary Edinburgh.

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Slide Source: Lipids Online Slide Library ASTEROID Population at Baseline (n=507) Patients Completing (n=349) Patients Not Completing.

Effect of on Oral Agent Inducing ApoA-I Synthesis on Progression of Coronary Atherosclerosis: Results of the ASSURE Study SJ Nicholls, CM Ballantyne, PJ.

VBWG Growth in heart disease, 2000–2050 Deaths Population Foot DK et al. J Am Coll Cardiol. 2000;35:

Flow of Patients Through the Trial Nissen SE, et al. JAMA 2008;299:

Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.

Www. Clinical trial results.org Cypher sirolimus-eluting stent Primary Endpoint:  In-stent and late lumen loss at 9 months (determined by QCA) Secondary.

Patient No 1 Baseline Final Follow-Up (7.1mo) Cypher 3.0/33 Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting.

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.

Slide Source: Lipids Online Slide Library Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Nissen SE et al. JAMA.

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prospective Application of Pre-Defined Intravascular.

The GREAT Trial. The Grampian Region Early Anistreplase Trial Reference Zahringer M, Sapoval M, Pattynama PM, et al. Sirolimus-eluting versus bare-metal.

The REVA Tyrosine-Derived Polycarbonate Bioresorbable Scaffold: Long-term Outcomes Using Multimodality Imaging Greg L. Kaluza, MD, PhD, FACC Director of.

Copyleft Clinical Trial Results. You Must Redistribute Slides ASTEROID Trial A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived.

Baseline Characteristics of the Patients Part I

Baseline Characteristics of 167 Patients Randomly Assigned to Either Placebo or Extended-Release Niacin Allen J. Taylor et al. Circulation 2004; 110:

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Treatment LDL-C: baseline (mg/dL) LDL-C: 24 mo (mg/dL) p

New Frontiers in Cardiology

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.

GLAGOV Trial design: Patients with CAD and elevated LDL cholesterol on statin therapy were randomized to subcutaneous evolocumab (n = 484) vs. subcutaneous.

Figure 2 Imaging of atherosclerotic plaque burden

Johannes Steiner et al. JACC 2017;70:

Volume 50, Issue 4, Pages (October 2006)

Coronary revascularisation rate (total 5

CT angiography results (vertical axis, N=count of patients): (A) total Coronary Calcium Score (CCS) (y-axis, Agatston Score), (B) coronary stenosis severity.

CT coronary angiography curved planar reconstruction of the left anterior descending coronary artery showing an atherosclerotic plaque with calcified and.

Volume 62, Issue 1, Pages (July 2002)

Baseline Characteristics

Clinical Characteristics and Atheroma Burden of Subjects at Baseline Stratified According to Gender Nicholls SJ. et al. J Am Coll Cardiol 2007;49:

Baseline Characteristics by Tertiles of Homocysteine

Flow of Patients Through the Trial

Flow of Patients Through Trial

Flow Diagram of the Trial Selection Process

Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.

Baseline Characteristics, Blood Pressures, and Laboratory Values

Baseline Characteristics of Study Populations

Morphologic changes of the saphenous vein Y-composite graft based on the left internal thoracic artery: 1-year intravascular ultrasound study Ho Young.

Baseline Characteristics of the Patients – Part I

Characteristics of SIRCA Participants

(A) Quantitative plaque analysis of the RCA

Correlation of calibrated integrated backscatter (cIB) with log10 total fibrosis (A) and log10 interstitial fibrosis (B) in patients undergoing coronary.

Scoring of Coronary Artery Disease Characteristics on Coronary CT Angiograms by Using Machine Learning For prediction of all-cause mortality on the basis.

Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:

Flow of study participants

Baseline characteristics of study population

Davide Capodanno et al. JCIN 2009;2:

Baseline Clinical and Angiographic Characteristics of All Patients With Aspirated Intracoronary Material (n211) S.Z.H. Rittersma, Circulation. 2005;111:

Angiographic findings in spontaneous coronary artery dissection.

A, Changes in BRAFV600E cfDNA allele fraction from baseline after one dose of treatment for 12 patients with serial samples available, classified according.

Presentation transcript:

Baseline Characteristics of the Patient Population (n=525) Colin Berry, et al. Circulation 2007;115:

Correlation Between Baseline QCA Data and Baseline IVUS Data for Matched Segments in the IVUS-Related Artery Colin Berry, et al. Circulation 2007;115:

Correlation Between Baseline QCA Data in All Coronary Arteries and Baseline IVUS Data in a Single Artery Colin Berry, et al. Circulation 2007;115:

Correlation between the coronary artery score on QCA and total lumen volume on IVUS at baseline Colin Berry, et al. Circulation 2007;115:

Correlation Between Change in QCA Measures in the IVUS-Related Artery and Change in Plaque Volume on IVUS Colin Berry, et al. Circulation 2007;115:

Correlation Between Change in QCA Measures for All Segments and Change in Plaque Volume on IVUS Colin Berry, et al. Circulation 2007;115:

Correlation Between Change in QCA Measures in the IVUS-Related Artery and Change in Percent Atheroma Volume on IVUS Colin Berry, et al. Circulation 2007;115:

Correlation Between Change in QCA Measures for All Segments and Change in Percent Atheroma Volume on IVUS Colin Berry, et al. Circulation 2007;115:

Comparison of IVUS Results in Patients With Angiographic Progression Versus No Progression by QCA in the IVUS-Related Artery Colin Berry, et al. Circulation 2007;115:

Changes in Plaque Volume* on IVUS From Baseline to Follow-Up According to 3 Values of Baseline Plaque Volume Colin Berry, et al. Circulation 2007;115: